Our lab is collaborating with the BRIGHTEN study and has launched PRIME for adults with depression. The app comes with a new name, PRIME-D, but has the same amazing features. The study is completely remote and you just need an iPhone. For those interested in PRIME-D, please visit the BRIGHTEN web portal (www.brightenstudy.com) and fill out the eligibility survey.
*Update: The study is closed; however, stay tuned as we may have more studies for depression on the way!
Research: PRIME mHealth app aims to improve the lives of individuals living with schizophrenia by enhancing their motivation to improve their quality of life.
“Current treatment approaches are failing to address one of the chief driver’s of disability in this population—impaired motivation. Our team is bridging the latest advances in the neuroscience of reward processing and digital health technology to address this unmet need, using PRIME (Personalized Real-time Intervention for Motivational Enhancement), a mobile health app. Working with IDEO, an award winning human-centered design firm, we have designed an intervention that inspires young people with schizophrenia to engage in health promoting behaviors by harnessing social motivation and gradual success experiences. The Catalyst Awards process played a pivotal role in finding the right strategic partners to move PRIME from a compelling idea to a product that will make a significant impact in peoples’ lives.”
- Danielle Schlosser, PhD | Assistant Adjunct Professor, UCSF School of Medicine | 2013 Catalyst Awards, Digital Health
“Fifty-one million people worldwide have schizophrenia. Over 2.2 million people are diagnosed with schizophrenia in the U.S. and it currently exceeds the cost of treating all the cancers combined, stroke, heart disease, diabetes, and a number of other health conditions.”
Could a simple cognitive training program transform schizophrenia from a debilitating disorder to a chronic but livable condition? (4:56)
Link to video Here
“The cliché is that if you’re schizophrenic you can’t do anything, you’re just disabled,” Pineda says. “But I like to think that I’m just like a regular person who just happens to take a pill once a day to keep me running — and that’s it.”
"Schlosser and her team have received funds from UCSF and the National Institute of Mental Health to further evolve Prime. Additionally, they've brought in 15 stakeholders, including those with personal connections to schizophrenia, to work out the kinks of the app."
"Traditional methods aren't more successful because they require you to come into the therapy office for an hour, every few weeks, and then take all that information and remember it and access it at critical moments in life," Schlosser explained.
Instead, the Prime app essentially puts support at the patient's fingertips, at a moment's notice.
"They needed to have a way to have this quick full list of education, connection, in a very brief interaction," she said.